Matches in Wikidata for { <http://www.wikidata.org/entity/Q94540272> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q94540272 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94540272 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94540272 description "scientific article published on 17 April 2020" @default.
- Q94540272 description "wetenschappelijk artikel" @default.
- Q94540272 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q94540272 name "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 name "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 type Item @default.
- Q94540272 label "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 label "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 prefLabel "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 prefLabel "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 P1433 Q94540272-4EE93782-6B36-4766-AE80-0E804FB6C878 @default.
- Q94540272 P1476 Q94540272-2418AA04-B97F-4048-94DF-638771ACD157 @default.
- Q94540272 P2093 Q94540272-0DBDD5EF-606F-4E89-9DEB-10BAEF58DCF0 @default.
- Q94540272 P2093 Q94540272-424072E9-6CCE-4166-89F7-D8D9796020A9 @default.
- Q94540272 P2093 Q94540272-4DAEAEDB-B7C3-4463-8A68-6C36083622DB @default.
- Q94540272 P2093 Q94540272-5C612B43-854A-4E8B-9F65-26C88247EDD0 @default.
- Q94540272 P2093 Q94540272-77591445-CAE3-4E7E-BF27-E4F4E95EFBA7 @default.
- Q94540272 P2093 Q94540272-C74E371C-35C4-4885-8F4E-582D8FA36E32 @default.
- Q94540272 P2093 Q94540272-CD0819D4-D196-4A5F-BF42-F9E6F0E2438B @default.
- Q94540272 P2093 Q94540272-E8704685-2A72-4329-99BA-FA8FB6EB6741 @default.
- Q94540272 P2093 Q94540272-EB9A4A99-4D71-4415-AFA1-293A2E8082FC @default.
- Q94540272 P304 Q94540272-6DDAEFDF-7704-4927-95BC-73035782A0B2 @default.
- Q94540272 P31 Q94540272-58E27836-90FA-44A2-9EBE-CF9082C7A113 @default.
- Q94540272 P356 Q94540272-EC0B99CD-0721-4BC4-98B0-89EF0BD11173 @default.
- Q94540272 P478 Q94540272-4CBA81E4-4352-40C5-8927-E29792B902B3 @default.
- Q94540272 P577 Q94540272-FD1D4831-8770-4D89-8CF6-E202B6FDF972 @default.
- Q94540272 P698 Q94540272-E8475F88-108F-4BB8-A9D9-77C8A38E6FD0 @default.
- Q94540272 P356 J.SEIZURE.2020.03.015 @default.
- Q94540272 P698 32380376 @default.
- Q94540272 P1433 Q15753758 @default.
- Q94540272 P1476 "The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre" @default.
- Q94540272 P2093 "Alice Brockington" @default.
- Q94540272 P2093 "Gary Dennis" @default.
- Q94540272 P2093 "Jon Dickson" @default.
- Q94540272 P2093 "Markus Reuber" @default.
- Q94540272 P2093 "Philippa Davies" @default.
- Q94540272 P2093 "Priya Shanmugarajah" @default.
- Q94540272 P2093 "Richard Grunewald" @default.
- Q94540272 P2093 "Stephen Howell" @default.
- Q94540272 P2093 "Theocharis Tsironis" @default.
- Q94540272 P304 "8-13" @default.
- Q94540272 P31 Q13442814 @default.
- Q94540272 P356 "10.1016/J.SEIZURE.2020.03.015" @default.
- Q94540272 P478 "79" @default.
- Q94540272 P577 "2020-04-17T00:00:00Z" @default.
- Q94540272 P698 "32380376" @default.